1208521

Boehringer Ingelheim Pharma GmbH & Co. KG — FEI 3002806556

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 7, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ingelheim am Rhein (Germany)

Additional Details

Mutual Recognition Agreement (MRA)